Back

prof. drs. D.E.E. (Marjolein) de Coenders-Pinas

prof. drs. D.E.E. (Marjolein) de Coenders-Pinas

Full Professor

Show full profile

Research Output (154)

Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis

Achten Roselie E, Van Luijk Chantal, Van der Rijst Lisa, Bakker Daphne, Spekhorst Lotte, Zuithoff Nicolaas, Schuttelaar Marie, Romeijn Geertruida, Voorberg Angelique, Kamsteeg Marijke, Haeck Inge, De Graaf Marlies, Thijs Judith, De Boer Joke, De Bruin-Weller Marjolein 31 Jan 2022, In: Acta Dermato-Venereologica. 102 , p. 1-7

Risk factors for conjunctivitis in atopic dermatitis patients treated with dupilumab: results from the bioday registry

Achten R., Van der Rijst L., Bakker D., Spekhorst L., Boesjes C., Zuithoff N., Knol E., Van Luijk C., De Boer J., Thijs J., De Graaf M., De Bruin-Weller M. Nov 2021, In: Allergy. 76 , p. 11-11

Unraveling heterogeneity in pediatric atopic dermatitis::identification of serum biomarker based patient clusters

Bakker D., de Graaf M., Nierkens S., Delemarre E., Knol E., van Wijk F., de Bruin-Weller M., Drylewicz J., Thijs J. Oct 2021, In: Journal of Investigative Dermatology. 141 , p. S189-S189

Conjunctival inflammation in dupilumab-treated atopic dermatitis comprises a multicellular infiltrate with elevated T1/T17 cytokines:A case series study

Bakker Daphne S., ter Linde José J.M., Amini Mojtaba M., Ariëns Lieneke F.M., van Luijk Chantal M., de Bruin-Weller Marjolein S., Thijs Judith L., Vercoulen Yvonne, van Wijk Femke 4 Sep 2021, In: Allergy. 76 , p. 3814-3817 4 p.

European Task Force on Atopic Dermatitis:position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics

Thyssen J P, Vestergaard C, Barbarot S, de Bruin-Weller M S, Bieber T, Taieb A, Seneschal J, Cork M J, Paul C, Flohr C, Weidinger S, Trzeciak M, Werfel T, Heratizadeh A, Darsow U, Simon D, Torrelo A, Chernyshov P V, Stalder J-F, Gelmetti C, Szalai Z, Svensson Å, von Kobyletzki L B, De Raeve L, Fölster-Holst R, Christen-Zaech S, Hijnen D J, Gieler U, Gutermuth J, Bangert C, Spuls P I, Kunz B, Ring J, Wollenberg A, Deleuran M 7 Mar 2021, In: JEADV : journal of the European Academy of Dermatology and Venereology. 35 , p. e308-e311

Early and Long-Term Effects of Dupilumab Treatment on Circulating T-Cell Functions in Patients with Moderate-to-Severe Atopic Dermatitis

Bakker D S, van der Wal M M, Heeb L E M, Giovannone B, Asamoah M, Delemarre E M, Drylewicz J, Nierkens S, Boyman O, de Bruin-Weller M S, Thijs J L, Wijk F van 18 Feb 2021, In: Journal of Investigative Dermatology. 141 , p. 1943-1953.e13

Treat-to-Target in Atopic Dermatitis:An International Consensus on a Set of Core Decision Points for Systemic Therapies

De Bruin-Weller Marjolein, Biedermann Tilo, Bissonnette Robert, Deleuran Mette, Foley Peter, Girolomoni Giampiero, Hercogová Jana, Hong Chih-Ho, Katoh Norito, Pink Andrew E, Richard Marie-Aleth, Shumack Stephen, Silvestre Juan F, Weidinger Stephan 17 Feb 2021, In: Acta Dermato-Venereologica. 101 , p. 1-7

Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials

Bieber T, Thyssen J P, Reich K, Simpson E L, Katoh N, Torrelo A, De Bruin-Weller M, Thaci D, Bissonnette R, Gooderham M, Weisman J, Nunes F, Brinker D, Issa M, Holzwarth K, Gamalo M, Riedl E, Janes J Feb 2021, In: JEADV : journal of the European Academy of Dermatology and Venereology. 35 , p. 476-485 10 p.

Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma

Bansal Ashish, Simpson Eric L, Paller Amy S, Siegfried Elaine C, Blauvelt Andrew, de Bruin-Weller Marjolein, Corren Jonathan, Sher Lawrence, Guttman-Yassky Emma, Chen Zhen, Daizadeh Nadia, Kamal Mohamed A, Shumel Brad, Mina-Osorio Paola, Mannent Leda, Patel Naimish, Graham Neil M H, Khokhar Faisal A, Ardeleanu Marius Jan 2021, In: American Journal of Clinical Dermatology. 22 , p. 101-115 15 p.

Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study

Bruin-Weller M.D., Pink A.E., Patrizi A., Gimenez-Arnau A.M., Agner T., Roquet-Gravy P.-P., Ferrucci S.M., Arenberger P., Svensson A., Schuttelaar M.L.A., Nosbaum A., Jayawardena S., Rizova E., Ardeleanu M., Eckert L., Ozturk Z.E. 2021, In: Journal of Dermatological Treatment. 32 , p. 164-173 10 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Contact

Afspraken

Praktisch

hetwkz.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not